title: Targeted therapy: Apatinib - new third-line option for refractory gastric or GEJ cancer.
authors.affiliation: Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-Ku, Yokohama 241-8515, Japan.
authors.forename: Toru
authors.initials: T
authors.lastname: Aoyama
authors.affiliation: Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-Ku, Yokohama 241-8515, Japan.
authors.forename: Takaki
authors.initials: T
authors.lastname: Yoshikawa
mesh_terms: D004943:Esophagogastric Junction; D006801:Humans; D009369:Neoplasms; D013274:Stomach Neoplasms